Peelaerts W, Bergkvist L, George S, Johnson M, Meyerdirk L, Schulz E, et al. Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits. FreeNeuropathol [Internet]. 2020 Nov. 25 [cited 2026 Mar. 12];1:33. Available from: https://www.uni-muenster.de/Ejournals/index.php/fnp/article/view/3049